28144577|t|Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7
28144577|a|To present the incidence of heterotopic ossification after the use of recombinant human bone morphogenetic protein-7 (rhBMP-7) for the treatment of nonunions. Bone morphogenetic proteins (BMPs) promote bone formation by auto-induction. Recombinant human BMP-7 in combination with bone grafts was used in 84 patients for the treatment of long bone nonunions. All patients were evaluated radiographicaly for the development of heterotopic ossification during the standard assessment for the nonunion healing. In all patients (80.9%) with radiographic signs of heterotopic ossification, a CT scan was performed. Nonunion site palpation and ROM evaluation of the adjacent joints were also carried out. Factors related to the patient (age, gender), the nonunion (location, size, chronicity, number of previous procedures, infection, surrounding tissues condition) and the surgical procedure (graft and fixation type, amount of rhBMP-7) were correlated with the development of heterotopic ossification and statistical analysis with Pearsons χ (2) test was performed. Eighty point nine percent of the nonunions treated with rhBMP-7, healed with no need for further procedures. Heterotopic bone formation occurred in 15 of 84 patients (17.8%) and it was apparent in the routine radiological evaluation of the nonunion site, in a mean time of 5.5 mo after the rhBMP-7 application (range 3-12). The heterotopic ossification was located at the femur in 8 cases, at the tibia in 6, and at the humerus in οne patient. In 4 patients a palpable mass was present and only in one patient, with a para-articular knee nonunion treated with rhBMP-7, the size of heterotopic ossification affected the knee range of motion. All the patients with heterotopic ossification were male. Statistical analysis proved that patient's gender was the only important factor for the development of heterotopic ossification (P = 0.007). Heterotopic ossification after the use of rhBMP-7 in nonunions was common but it did not compromise the final clinical outcome in most cases, and affected only male patients.
28144577	0	24	Heterotopic ossification	T046	C0029396
28144577	42	88	recombinant human bone morphogenetic protein-7	T116,T121	C1445625
28144577	104	113	incidence	T081	C0021149
28144577	117	141	heterotopic ossification	T046	C0029396
28144577	159	205	recombinant human bone morphogenetic protein-7	T116,T121	C1445625
28144577	207	214	rhBMP-7	T116,T121	C1445625
28144577	224	233	treatment	T061	C0087111
28144577	237	246	nonunions	T033	C3897107
28144577	248	275	Bone morphogenetic proteins	T116,T123	C0053932
28144577	277	281	BMPs	T116,T123	C0053932
28144577	291	305	bone formation	T042	C0029433
28144577	309	323	auto-induction	T044	C1148560
28144577	325	348	Recombinant human BMP-7	T116,T121	C1445625
28144577	369	380	bone grafts	T122	C0181075
28144577	396	404	patients	T101	C0030705
28144577	413	422	treatment	T061	C0087111
28144577	426	445	long bone nonunions	T033	C3897107
28144577	451	459	patients	T101	C0030705
28144577	465	474	evaluated	T058	C0220825
28144577	475	490	radiographicaly	T060	C0841672
28144577	499	510	development	T169	C1527148
28144577	514	538	heterotopic ossification	T046	C0029396
28144577	550	558	standard	T080	C1442989
28144577	559	569	assessment	T058	C0220825
28144577	578	586	nonunion	T033	C3897107
28144577	587	594	healing	T040	C0043240
28144577	603	611	patients	T101	C0030705
28144577	625	637	radiographic	T070	C0444708
28144577	638	643	signs	T184	C0037088
28144577	647	671	heterotopic ossification	T046	C0029396
28144577	675	682	CT scan	T060	C0040405
28144577	698	706	Nonunion	T033	C3897107
28144577	707	711	site	T082	C0205145
28144577	712	721	palpation	T060	C0030247
28144577	726	740	ROM evaluation	T059	C1562926
28144577	748	756	adjacent	T082	C0205117
28144577	757	763	joints	T030	C0022417
28144577	787	794	Factors	T169	C1521761
28144577	810	817	patient	T101	C0030705
28144577	819	822	age	T032	C0001779
28144577	824	830	gender	T032	C0079399
28144577	837	845	nonunion	T033	C3897107
28144577	847	855	location	T082	C0450429
28144577	857	861	size	T082	C0456389
28144577	863	873	chronicity	T079	C0547045
28144577	875	904	number of previous procedures	T169	C2700391
28144577	906	915	infection	T046	C3714514
28144577	917	928	surrounding	T082	C1282914
28144577	929	936	tissues	T024	C0040300
28144577	937	946	condition	T080	C0348080
28144577	956	974	surgical procedure	T061	C0543467
28144577	976	981	graft	T122	C0181074
28144577	986	994	fixation	T061	C0185023
28144577	995	999	type	T080	C0332307
28144577	1001	1007	amount	T081	C1265611
28144577	1011	1018	rhBMP-7	T116,T121	C1445625
28144577	1025	1035	correlated	T080	C1707520
28144577	1045	1056	development	T169	C1527148
28144577	1060	1084	heterotopic ossification	T046	C0029396
28144577	1089	1109	statistical analysis	T062	C0871424
28144577	1115	1134	Pearsons χ (2) test	T170	C0237913
28144577	1183	1192	nonunions	T033	C3897107
28144577	1193	1200	treated	T169	C1522326
28144577	1206	1213	rhBMP-7	T116,T121	C1445625
28144577	1215	1221	healed	T169	C0205249
28144577	1247	1257	procedures	T169	C2700391
28144577	1259	1285	Heterotopic bone formation	T046	C0029396
28144577	1307	1315	patients	T101	C0030705
28144577	1359	1382	radiological evaluation	T058	C0220825
28144577	1390	1398	nonunion	T033	C3897107
28144577	1410	1419	mean time	T079	C0040223
28144577	1440	1447	rhBMP-7	T116,T121	C1445625
28144577	1448	1459	application	T169	C4048755
28144577	1478	1502	heterotopic ossification	T046	C0029396
28144577	1522	1527	femur	T023	C0015811
28144577	1533	1538	cases	T077	C1706256
28144577	1547	1552	tibia	T023	C1279118
28144577	1570	1577	humerus	T023	C0020164
28144577	1585	1592	patient	T101	C0030705
28144577	1599	1607	patients	T101	C0030705
28144577	1610	1623	palpable mass	T033	C0746412
28144577	1652	1659	patient	T101	C0030705
28144577	1668	1696	para-articular knee nonunion	T033	C3897107
28144577	1697	1704	treated	T169	C1522326
28144577	1710	1717	rhBMP-7	T116,T121	C1445625
28144577	1723	1727	size	T082	C0456389
28144577	1731	1755	heterotopic ossification	T046	C0029396
28144577	1769	1789	knee range of motion	T033	C0576094
28144577	1799	1807	patients	T101	C0030705
28144577	1813	1837	heterotopic ossification	T046	C0029396
28144577	1843	1847	male	T032	C0086582
28144577	1849	1869	Statistical analysis	T062	C0871424
28144577	1882	1891	patient's	T101	C0030705
28144577	1892	1898	gender	T032	C0079399
28144577	1922	1928	factor	T169	C1521761
28144577	1937	1948	development	T169	C1527148
28144577	1952	1976	heterotopic ossification	T046	C0029396
28144577	1990	2014	Heterotopic ossification	T046	C0029396
28144577	2032	2039	rhBMP-7	T116,T121	C1445625
28144577	2043	2052	nonunions	T033	C3897107
28144577	2100	2116	clinical outcome	T169	C1274040
28144577	2125	2130	cases	T077	C1706256
28144577	2150	2154	male	T032	C0086582
28144577	2155	2163	patients	T101	C0030705